NEWS
- Celebrate Thanksgiving with 30% Off Monodispersed PEGs!
- Positive Trial Results of Semaglutide for MASH
- Claudin 18.2: A Promising New Target for Breakthrough Cancer Treatments
- Emerging Trends in the Development of GLP-1 Receptor Agonists
- Monodispersed PEGs for Your ADC & PROTAC Development
- Insights into Ophthalmic Drug Innovations and Market Trends
- Aptamer Therapeutics: Current Status
- TIDES USA, May 2024, Booth #935
- BIO International Convention in June 2024, Booth 5102
- PEGS Boston Summit, May 2024, Booth #718
